Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: health

There are two kinds of people in Washington, DC, says entrepreneur Dean Kamen. There are the policy experts, whom he calls cynics. And there are the scientists, whom he deems optimists.

Kamen, speaking at the White House Frontiers Conference at the University of Pittsburgh, places himself in the latter camp. Unlike policy wonks and politicians who see diseases like Alzheimer’s or ALS as unstoppable scourges, Kamen points out that previously terrifying diseases were all toppled by medical innovation. The plague, polio, smallpox — all were civilization-threatening epidemics until experimental scientists discovered new ways to combat them.

If that sounds like the kind of disruption that the tech industry has unleashed across the rest of the world, that’s no accident. Kamen, the founder of DEKA, a medical R&D company, says that the same trends that have empowered our computers and phones and communication networks will soon power a revolution in health care. He says that medical innovation follows a predictable cycle. First we feel powerless before a disease. Then we seek ways of treating it. Then we attempt to cure it.

Read more

(credit: iStock)

In the first controlled clinical trial of nicotinamide riboside (NR), a newly discovered form of Vitamin B3, researchers have shown that the compound is safe for humans and increases levels of a cell metabolite called NAD+ that is critical for cellular energy production and protection against stress and DNA damage.

Levels of NAD+ (first discovered by biochemists in 1906) diminish with age, and it has been suggested that loss of this metabolite may play a role in age-related health decline.

Read more

Follow along with the Exponential Medicine 2016 livestream, presented by Guidewell. Join Singularity University as we explore the convergence of health and technology to catalyze the future of medicine.

Join us on Twitter @ExponentialMed and with #xmed.

Connect with Singularity University:
Website: http://singularityu.org

Singularity HUB: http://singularityhub.com

Facebook: https://www.facebook.com/singularityu

Twitter: https://twitter.com/singularityu

Read more

Xconomy National —

Drugs that use molecular scissors to snip out or replace defective genes. Altered mosquitoes meant to sabotage entire disease-carrying populations. Both are potential uses of genome editing, which thanks to the CRISPR-Cas9 system has spread throughout the world’s biology labs and is now on the doorstep of the outside world. But with its first applications could also come unintended consequences for human health and the environment. The U.S. Defense Advanced Research Projects Agency—a famed military R&D group—wants to finance safety measures for the new gene-editing age.

The idea for the funding program, called Safe Genes, is to get out ahead of problems that could bring the field to a screeching halt. “We should couple innovation with biosecurity,” DARPA program manager Renee Wegrzyn, said Tuesday at the SynBioBeta conference in South San Francisco. “We need new safety measures that don’t slow us down. You have brakes in your car so that you can go fast but can stop when you need to.”

Read more

Classifying aging as a disease, the debate is hotting up as ICD11 at WHO draws near.

What is considered to be normal and what is considered to be diseased is strongly influenced by historical context (Moody, ). Matters once considered to be diseases are no longer classified as such. For example, when black slaves ran away from plantations they were labeled to suffer from drapetomania and medical treatment was used to try to “cure” them (Reznek, ). Similarly, masturbation was seen as a disease and treated with treatments such as cutting away the clitoris or cauterizing it (Reznek, ). Finally, homosexuality was considered a disease as recently as 1974 (Reznek, ). In addition to the social and cultural influence on disease definition, new scientific and medical discoveries lead to the revision of what is a disease and what is not (Butler, ). For example, fever was once seen as a disease in its own right but the realization that different underlying causes would lead to the appearance of fever changed its status from disease to symptom (Reznek, ). Conversely, several currently recognized diseases, such as osteoporosis, isolated systolic hypertension, and senile Alzheimer’s disease, were in the past ascribed to normal aging (Izaks and Westendorp, ; Gems, ). Osteoporosis was only officially recognized as a disease in 1994 by the World Health Organization (WHO, ).

Disease is a complex phenomenon and a current definition must consider both a biological and social explanation. The medical definition of disease is any abnormality of bodily structure or function, other than those arising directly from physical injury; the latter, however, may open the way for disease (Marcovitch, ). The disorder has a specific cause and recognizable signs and symptoms, and can affect humans, other animals, and plants (Martin, ). The social aspect of disease is significant when trying to divide a line between a healthy and a pathological state. This is a highly context and value driven process and, considering the WHO definition of health as a “state of complete physical, mental, and social well-being and not merely the absence of disease or infirmity,” it is not as simple as classifying disease as the opposite of health (WHO, ). “Someone starving to death is not taken to have a disease, but is still not considered healthy” (Reznek, ).

Read more

How society can profit from treating age-related diseases.

We’re now living longer than ever – only to suffer from diseases of old age. New therapies promise a new lease of life for the elderly – and big profits for investors, says Matthew Partridge.

Over the past century, average life expectancy in most countries has grown substantially. Vastly lower infant mortality, improved living standards, better public sanitation, and the discovery of cures or vaccines for many once-deadly diseases, have seen average life expectancy in most developed nations rise to around 80, compared with 50 in 1900. Developing nations have benefited too. Life expectancy in China, for example, was just 43 in 1960 – it’s 75 today. Indeed, according to the World Health Organisation, no individual nation outside Africa now has a life expectancy of below 60, and even Africa has seen huge gains since 2000, helped by improved anti-malarial measures and wider availability of HIV/Aids treatments.

However, the pace of progress is slowing. From 1900, it took less than 30 years for life expectancy in the US to rise from 50 to 60 years. It took another 40 years to rise to 70, and now, nearly 50 years later, it is still hovering at just below 80. The problem is that while we’ve largely beaten the diseases that used to kill people in childhood, early adulthood and even middle age, we’re having much less success in prolonging the life of the elderly. Here’s a stark illustration: in Britain in 1840, if you made it to 65, you could expect, on average, to die at age 76. In 2011, a 65-year-old could expect to die aged 83. In other words, today you have a far better chance of living to 65 than you did 170-odd years ago. But if you do, your remaining life expectancy won’t be much greater than that of your 19th-century peers.

Read more

I never get tired in circuitry thread and any new findings.

Tufts University engineers say that revolutionary health diagnostics may be hanging on a thread—one of many threads they have created that integrate nano-scale sensors, electronics and microfluidics into threads ranging from simple cotton to sophisticated synthetics. “We think thread-based devices could potentially be used as smart sutures for surgical implants, smart bandages to monitor wound healing, or integrated with textile or fabric as personalized health monitors and point-of-care diagnostics,” says Sameer Sonkusale, Ph.D., director of the interdisciplinary Nano Lab in the Department of Electrical and Computer Engineering at Tufts School of Engineering, Medford/Somerville, Mass.

Researchers dipped a variety of conductive threads in physical and chemical sensing compounds and connected them to wireless electronic circuitry. The threads, sutured into tissues of rats, collected data on tissue health (pressure, stress, strain and temperature), pH and glucose levels. The data helps determine how wounds are healing, whether infection is emerging or whether the body’s chemistry is out of balance. Thread’s natural wicking properties draw fluids to the sensing compounds. Resulting data is transmitted wirelessly to a cell phone and computer.

To date, substrates for implantable devices have been two-dimensional, expensive and difficult to process, making them suitable for flat tissue, such as skin, but not for organs. “By contrast, thread is abundant, inexpensive, thin and flexible, and can be easily manipulated into complex shapes,” says Pooria Mostafalu, Ph.D., postdoctoral research fellow with the Harvard-MIT Division of Health Sciences and Technology and former Tufts doctoral student.

Read more

If the 1967 film “The Graduate” were remade today, Mr. McGuire’s famous advice to young Benjamin Braddock would probably be updated to “Plastics … with nanoparticles.” These days, the mechanical, electrical and durability properties of polymers—the class of materials that includes plastics—are often enhanced by adding miniature particles (smaller than 100 nanometers or billionths of a meter) made of elements such as silicon or silver. But could those nanoparticles be released into the environment after the polymers are exposed to years of sun and water—and if so, what might be the health and ecological consequences?

In a recently published paper, researchers from the National Institute of Standards and Technology (NIST) describe how they subjected a commercial nanoparticle-infused coating to NIST-developed methods for accelerating the effects of weathering from ultraviolet (UV) radiation and simulated washings of rainwater. Their results indicate that humidity and exposure time are contributing factors for nanoparticle release, findings that may be useful in designing future studies to determine potential impacts.

In their recent experiment, the researchers exposed multiple samples of a commercially available polyurethane coating containing silicon dioxide nanoparticles to intense UV radiation for 100 days inside the NIST SPHERE (Simulated Photodegradation via High-Energy Radiant Exposure), a hollow, 2-meter (7-foot) diameter black aluminum chamber lined with highly UV reflective material that bears a casual resemblance to the Death Star in the film “Star Wars.” For this study, one day in the SPHERE was equivalent to 10 to 15 days outdoors. All samples were weathered at a constant temperature of 50 degrees Celsius (122 degrees Fahrenheit) with one group done in extremely dry conditions (approximately 0 percent humidity) and the other in humid conditions (75 percent humidity).

Read more

MIT researchers have designed nanosensors that can profile tumors and may yield insight into how they will respond to certain therapies. The system is based on levels of enzymes called proteases, which cancer cells use to remodel their surroundings.

Once adapted for humans, this type of sensor could be used to determine how aggressive a tumor is and help doctors choose the best treatment, says Sangeeta Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science and a member of MIT’s Koch Institute for Integrative Cancer Research.

“This approach is exciting because people are developing therapies that are protease-activated,” Bhatia says. “Ideally you’d like to be able to stratify patients based on their protease activity and identify which ones would be good candidates for these therapies.”

Read more

Please sign this petition to the NIH to help get more funding for aging research.

Every year about two million Americans die of illnesses doctors cannot cure. Cancer afflicts 50% of men and 30% of women. Five hundred and ninety five thousand Americans will die of cancer this year. Millions get heart diseases, strokes, etc. Every year 1,612,552 Americans die of the top 8 illnesses that doctors are unable to cure. Over a 30-year period, 48,376,560 United States citizens will die of the top 8 illnesses. Let us not forget other disabling and potentially curable illnesses. How much is it worth to save them? We have the resources and opportunity to cure age-related disease.

History has shown that medical research actually saves money. We now spend three trillion two hundred billion dollars yearly for health care. The health care expenditures will increase as our population grows with more senior citizens.

Every year we also spend hundreds of billions of dollars for services such as Social Security Disability, welfare, food stamps, special transportation, etc. Medical research will help cut down on the need for these services. It will also extend our lives.

Read more